These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35589385)

  • 41. A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.
    Yamada T; Morita T; Maeda I; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Ono S; Ozawa T; Yamamoto R; Shishido H; Yamamoto N
    Cancer; 2017 Apr; 123(8):1442-1452. PubMed ID: 27926777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
    Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
    Front Oncol; 2022; 12():913731. PubMed ID: 36016629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simple prognostic model for patients with advanced cancer based on performance status.
    Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
    J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs.
    Deng C; Zhang N; Wang Y; Jiang S; Lu M; Huang Y; Ma J; Hu C; Hou T
    Medicine (Baltimore); 2019 Aug; 98(33):e16875. PubMed ID: 31415428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status.
    Azad AA; Eigl BJ; Leibowitz-Amit R; Lester R; Kollmannsberger C; Murray N; Clayton R; Heng DY; Joshua AM; Chi KN
    Eur Urol; 2015 Mar; 67(3):441-7. PubMed ID: 24508071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Roles of Inflammation- and Nutrition-Based Indicators for Female Patients with Cancer.
    Yang M; Zhang Q; Ge Y; Tang M; Hu C; Wang Z; Zhang X; Song M; Ruan G; Zhang X; Liu T; Xie H; Zhang H; Zhang K; Li Q; Li X; Liu X; Lin S; Shi H
    J Inflamm Res; 2022; 15():3573-3586. PubMed ID: 35747251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.
    Murakawa Y; Sakayori M; Otsuka K
    BMC Palliat Care; 2019 Jun; 18(1):45. PubMed ID: 31159782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
    Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
    Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer.
    Iwai N; Okuda T; Sakagami J; Harada T; Ohara T; Taniguchi M; Sakai H; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Yasuda H; Naito Y; Itoh Y
    Sci Rep; 2020 Oct; 10(1):18758. PubMed ID: 33127996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a Novel Predictive-Prognostic Scoring Index for Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer.
    Diker O; Olgun P; Balyemez U; Sigit Ikiz S
    Cureus; 2023 Jan; 15(1):e33234. PubMed ID: 36733552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-A systematic review and meta-analysis of real world data.
    Dall'Olio FG; Maggio I; Massucci M; Mollica V; Fragomeno B; Ardizzoni A
    Lung Cancer; 2020 Jul; 145():95-104. PubMed ID: 32417680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic Value of Ferritin-to-Hemoglobin Ratio in Patients with Advanced Non-Small-Cell Lung Cancer.
    Lee S; Jeon H; Shim B
    J Cancer; 2019; 10(7):1717-1725. PubMed ID: 31205527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.
    Buccheri G; Ferrigno D; Tamburini M
    Eur J Cancer; 1996 Jun; 32A(7):1135-41. PubMed ID: 8758243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma.
    Yugawa K; Itoh S; Yoshizumi T; Morinaga A; Iseda N; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Int J Clin Oncol; 2021 Oct; 26(10):1901-1910. PubMed ID: 34117554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer.
    Badora-Rybicka A; Nowara E; Starzyczny-Słota D
    ESMO Open; 2016; 1(2):e000039. PubMed ID: 27843595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.
    Iseda N; Itoh S; Yoshizumi T; Tomiyama T; Morinaga A; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oda Y; Mori M
    Int J Clin Oncol; 2021 Oct; 26(10):1890-1900. PubMed ID: 34251555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Eastern Cooperative Oncology Group Performance Status as a prognostic factor of stage I-III colorectal cancer surgery for elderly patients: a multi-institutional retrospective analysis.
    Hanaoka M; Hino H; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Kato S; Yamauchi S; Kinugasa Y; Sugihara K
    Surg Today; 2022 Jul; 52(7):1081-1089. PubMed ID: 35039939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
    Sun L; Zhu Y; Qian Q; Tang L
    Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.